Gladius Capital Management’s Opko Health OPK Stock Holding History

Gladius Capital Management’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-24,746	Closed	-$30.9K	–	418
2022 Q4	$30.9K	Buy	+24,746	New	+$39K	﹤0.01%	299

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Gladius Capital Management's OPK Position: Q1 2023 in Review

Gladius Capital Management sold out of Opko Health (OPK) in Q1 2023, closing a stake of 24,746 shares — an estimated $30.9K sold.

Gladius Capital Management first reported a position in OPK in Q4 2022 and held it in 1 quarter. The position peaked at $30.9K in Q4 2022. 227 funds tracked by Wall St. Rank hold OPK as of Q1 2023.

Gladius Capital Management reported no remaining Opko Health position as of Q1 2023 after selling out during the quarter.
Gladius Capital Management sold 24,746 Opko Health shares in Q1 2023, an estimated $30.9K.
Gladius Capital Management first reported a position in Opko Health in Q4 2022 and held it in 1 quarter.
Gladius Capital Management's Opko Health position peaked at $30.9K in Q4 2022.
227 funds tracked by Wall St. Rank held Opko Health as of Q1 2023.

Based on Gladius Capital Management's 13F filing for Q1 2023, filed 9 May 2023.